GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » Long-Term Debt

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Long-Term Debt : ¥576 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co Long-Term Debt?

Ningbo Menovo Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2025 was ¥576 Mil.

Ningbo Menovo Pharmaceutical Co's quarterly Long-Term Debt increased from Sep. 2024 (¥643 Mil) to Dec. 2024 (¥652 Mil) but then declined from Dec. 2024 (¥652 Mil) to Mar. 2025 (¥576 Mil).

Ningbo Menovo Pharmaceutical Co's annual Long-Term Debt increased from Dec. 2022 (¥675 Mil) to Dec. 2023 (¥744 Mil) but then declined from Dec. 2023 (¥744 Mil) to Dec. 2024 (¥652 Mil).


Ningbo Menovo Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Ningbo Menovo Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningbo Menovo Pharmaceutical Co Long-Term Debt Chart

Ningbo Menovo Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.51 727.31 675.25 743.96 651.62

Ningbo Menovo Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 730.27 681.58 643.49 651.62 576.22

Ningbo Menovo Pharmaceutical Co  (SHSE:603538) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Ningbo Menovo Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Ningbo Menovo Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
Executives
Xu Jian senior management
Cao Qian Director
Yao Fang Director
Ying Gao Feng Director
Sun Yan Director
Shi Jian Xiang Director
Wu Feng Yun Director
Tu Ying Director
Yao Cheng Zhi Director
Zheng Hui Lin Supervisors
Jiao Hua senior management

Ningbo Menovo Pharmaceutical Co Headlines

No Headlines